Drug · DIN 02460904
VIBERZI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 3, 2025; first marketed April 24, 2017.
- Drug Identification Number (DIN)
- 02460904
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eluxadoline A07DA06
- Class
- Human
- Record last updated
- May 2, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELUXADOLINE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 25, 2024: NOC 33521New Drug Submission (NDS) · Merger/Buy-out. Product Monograph reformatted to the Master Template . Update to package insert. Update to package labels
- April 29, 2019: NOC 22113New Drug Submission (NDS) · Merger - buyout
- January 26, 2017: NOC 18907New Drug Submission (NDS)
Other DINs named VIBERZI
- DIN 02460890 · Marketed